期刊文献+

NAD^+的多形态和不规则

Polymorphism and Disorder of NAD^+
下载PDF
导出
摘要 此研究采用理论计算得出NAD^+的优化结构为环形。NAD^+中有五个较强的O-H和N—H拉伸振动方式。经研究,由于O-H…O和N-H…N氢键的方向不同,发现了NAD^+许多重要形式中的五种多形态。NAD^+呈环状,能与一些分子反应。应用剪切力的概念,讨论了NAD^+多形态的机理。说明了NAD^+的作用机理。NAD^+是一种辅酶,由于形状的改变而成为不规则,即NAD^+呈现多形态。在NAD^+的多形态中,最稳定的结构具有最小的熵。经热力学研究发现,NAD^+的多形态和低熵值归因于反应中的负Gibbs自由能。讨论了NAD^+的多形态对其与食物反应的影响。至于NAD^+的不规则,它取决于NAD^+分子周围分子的本身性质。 In the research, the optimized structure of NAD^+ was calculated to get a ring shape based on theoretical calculations. There are five stronger O-H and N-H stretches in NAD^+. Based on investigation, NAD^+ has many important forms which mean that it has polymorphisms in which five polymorphisms are found due to various directions of hydrogen bonds of O-H…O and N-H…N. NAD^+ can react with molecules based on ring shapes. The mechanism ofpolymorphism of NAD^+ was discussed by exerting the concept of shearing force. The mechanism of how NAD^+ works was illustrated. NAD^+ is a coenzyme, it will be disorder because of shape changing, namely the polymorphism of NAD^+. In polymorphisms of NAD^+, the most stable structure has the smallest entropy. The thermodynamic study found the polymorphism and low entropy of NAD^+ can contribute to the negative Gibbs free energy in reactions. The effects of polymorphism of NAD^+ on reactions with foods were discussed. As for the disorder of NAD^+, it is dependent on the nature of molecules surrounding the NAD^+ molecule.
作者 邢波
出处 《现代科学仪器》 2014年第3期242-248,共7页 Modern Scientific Instruments
关键词 NAD^+ 多形态 不规则 计算化学 NAD^+ Polymorphism Disorder Computational chemistry
  • 相关文献

参考文献23

  • 1Fabiola Olivieri,Roberto Antonicelli,Maurizio Cardelli,Francesca Marchegiani,Luca Cavallone,Eugenio Mocchegiani, Claudio Franceschi,Mechanisms of Ageing and Development 127 (2006) 552- 559.
  • 2Leigh J.Keen,Transplant Immunology lO (2002). 143-146.
  • 3Shagun Aggarwal,Farah Parveen,Rehan Mujeeb Faridi,Shubha Phadke,Minal Borkar,Suraksha Agrawal,Reproductive BioMedicine Online 22 (2011) 59- 64.
  • 4George E.Theodoropoulos,Nikolaos V.Michalopoulos,Malena P.Pantou,Panagiota Kontogianni,Maria Gazouli,Theodoros Karantanos,Maria Lymperi,George C.Zografos,Cancer Genetics 205 (2012) 508-512.
  • 5N.H. Cartwright,L.J.Keen,A.G.Demaine,N. J.Hurlock,R.J.McGonigle,P.A.Rowe,J.F.Shaw,R.M.Szydlo,E. R.Kaminski,Transplant Immunology 8 (2001) 237-244.
  • 6L. Qui ones, F. Berthou, N. Varela, B. Simon, L. Gil, D. Lucas, Cancer Letters 141 (1999) 167-171.
  • 7Barbara S.Nepom,David A.Schwarz, Janet V. Johnston,and Susan F.Radka, Human Immunology 25 (1989) 257-267.
  • 8Peter A. Fasching,Simon Gayther, Leigh Pearce, Joellen M.Schildkraut, Ellen Goode, Falk Thiel, Georgia Chenevix-Trench, Jenny Chang-Claude,Shah Wang-Gohrke,Susan Ramus,Paul Pharoah,Andrew Berchuck,MOLECULAR ONCOLOGY 3 (2009) 171 181.
  • 9Mahmoud I. Mahmoud, Heba Sh. Kassem, Nashwa H. Abdel Wahab, Abeer A.Saad, Pacint Moez, Alexandria Journal of Medicine 47 (2011) 105-115.
  • 10Hannu Norppa,Toxicology Letters 149 (2004) 309- 334.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部